NCT03304678 2026-02-18
Discovery of Sirolimus Sensitive Biomarkers in Blood
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
6 trialsNCT00414648 2023-11-02
MILES
University of Cincinnati
Phase 3 Completed
NCT03253913 2023-02-01
RESULT
University of Cincinnati
Phase 2 Completed
NCT02061397 2020-08-25
SOS
University of Pennsylvania
Phase 1/2 Completed
NCT01687179 2018-10-11
SAIL
Brigham and Women's Hospital
Phase 1 Completed
NCT00457808 2007-04-09
Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM
Children's Hospital Medical Center, Cincinnati
Phase 2 Completed